Elisabeth Botelho-Nevers

Elisabeth Botelho-Nevers is a Professor and hospital practitioner at the Saint-Etienne University Hospital Center in France. With a Doctor of Medicine degree and DES in Internal Medicine (thesis defended in Marseille on October 1, 2008), she further specialized with a doctoral thesis in human pathology defended on September 8, 2011 at the Faculty of Medicine of Marseille. Her academic and clinical work focuses on infectious diseases, particularly in the context of emerging pathogens and vaccine-related issues.

Dr. Botelho-Nevers' research interests span multiple areas of infectious diseases:

• COVID-19 epidemiology, treatment, and vaccination strategies
• Vaccine safety, efficacy, and public health implementation
• Infective endocarditis and cardiovascular infections
• Neuroinfectious diseases and encephalitis
• Antimicrobial stewardship and appropriate antibiotic use
• Global health disparities in infectious disease management

Her extensive publication record demonstrates significant contributions to understanding the clinical management of infectious diseases, with particular emphasis on the COVID-19 pandemic. Her work has appeared in high-impact journals including The Lancet Infectious Diseases, Clinical Infectious Diseases, and Nature Medicine. Dr. Botelho-Nevers frequently collaborates on multinational studies, reflecting her prominence in the global infectious disease research community.

Notable scientific contributions include:

• Research on the French health pass system and its implications for mandatory vaccination policies
• Studies evaluating diagnostic criteria for infective endocarditis
• Investigations into vaccine coadministration and safety during febrile illness
• Analysis of long-term neurological symptoms following COVID-19 infection
• Work on antimicrobial stewardship in elderly populations

As a hospital practitioner and researcher, Dr. Botelho-Nevers bridges clinical practice with academic research, contributing significantly to evidence-based approaches in infectious disease management. Her ongoing work continues to shape understanding and treatment protocols for infectious diseases in both national and international contexts.